Changing Operative Characteristics of Patients Undergoing Operations for Coronary Artery Disease: Impact on Early Outcomes

Annals of Thoracic Surgery

Volumn 86, Issue 5, 2008, Pages 1424-1430

  Ngaage, Dumbor L ^a   Griffin, Steven ^a   Guvendik, Levent ^a   Cowen, Michael E ^a   Cale, Alexander R J ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ;

ADULT; AGED; ANGIOPLASTY; ARTICLE; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIALYSIS; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STROKE; SURGICAL MORTALITY; SURGICAL RISK; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARDIAC SURGICAL PROCEDURES; CORONARY DISEASE; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PERIOPERATIVE CARE; TREATMENT OUTCOME;

EID: 53849143281     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.07.050     Document Type: Article

References (28)

1. Al-Mallah M.H., Tleyjeh I.M., Abdel-Latif A.A., and Weaver W.D. Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: a systematic review and meta-analysis of randomized controlled trials. J Am Coll Cardiol 47 (2006) 1576-1583
2. Biondi-Zoccai G.G., Lotrionte M., Agostoni P., et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 27 (2006) 2667-2674
3. Dropinski J., Jakiela B., Sanak M., et al. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin. Thromb Haemost 98 (2007) 201-209
4. Jenkins N.P., Keevil B.G., Hutchinson I.V., and Brooks N.H. Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease. Am J Med 112 (2002) 269-274
5. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet 360 (2002) 965-970
6. Mercado N., Wijns W., Serruys P.W., et al. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg 130 (2005) 512-519
7. Yang Z.K., Shen W.F., Zhang R.Y., et al. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease. J Interv Cardiol 20 (2007) 10-16
8. Zhang Z., Weintraub W.S., Mahoney E.M., et al. Relative benefit of coronary artery bypass grafting versus stent-assisted percutaneous coronary intervention for angina pectoris and multivessel coronary disease in women versus men (one-year results from the Stent or Surgery trial). Am J Cardiol 93 (2004) 404-409
9. Silber S., Albertsson P., Aviles F.F., et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26 (2005) 804-847
10. Ferguson Jr. T.B., Hammill B.G., Peterson E.D., DeLong E.R., and Grover F.L. A decade of change-risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg 73 (2002) 480-489 discussion 9-90
11. Grover F.L., Shroyer A.L., Hammermeister K., et al. A decade's experience with quality improvement in cardiac surgery using the Veterans Affairs and Society of Thoracic Surgeons national databases. Ann Surg 234 (2001) 464-472 discussion 72-4
12. Carrier M., Perrault L.P., Jeanmart H., Martineau R., Cartier R., and Page P. Randomized trial comparing off-pump to on-pump coronary artery bypass grafting in high-risk patients. Heart Surg Forum 6 (2003) E89-E92
13. Jacobs S., Holzhey D., Falk V., Garbade J., Walther T., and Mohr F.W. High-risk patients with multivessel disease-is there a role for incomplete myocardial revascularization via minimally invasive direct coronary artery bypass grafting?. Heart Surg Forum 10 (2007) E459-E462
14. Jensen B.O., Hughes P., Rasmussen L.S., Pedersen P.U., and Steinbruchel D.A. Health-related quality of life following off-pump versus on-pump coronary artery bypass grafting in elderly moderate to high-risk patients: a randomized trial. Eur J Cardiothorac Surg 30 (2006) 294-299
15. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 96 (1997) 1761-1769
16. Pell J.P., Pell A.C., Jeffrey R.R., et al. Comparison of survival following coronary artery bypass grafting vs. percutaneous coronary intervention in diabetic and non-diabetic patients: retrospective cohort study of 6320 procedures. Diabet Med 21 (2004) 790-792
17. Eckardt R., Kjeldsen B.J., Thayssen P., et al. Frequent change of procedure during coronary artery bypass surgery suggests insufficient preoperative diagnostic strategy. Interact Cardiovasc Thorac Surg 6 (2007) 298-302
18. Rosenfeld K., Luft H.S., Garnick D.W., and McPhee S.J. Changes in patient characteristics and surgical outcomes for coronary artery bypass surgery 1972-82. Am J Public Health 77 (1987) 498-500
19. Haraphongse M., Na-Ayudhya R.K., Teo K.K., et al. The changing clinical profile of coronary artery bypass graft patients, 1970-89. Can J Cardiol 10 (1994) 71-76
20. Parsonnet V., Dean D., and Bernstein A.D. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 79 (1989) I3-I12
21. Nashef S.A., Roques F., Michel P., Gauducheau E., Lemeshow S., and Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16 (1999) 9-13
22. Hattler B.G., Madia C., Johnson C., et al. Risk stratification using the Society of Thoracic Surgeons Program. Ann Thorac Surg 58 (1994) 1348-1352
23. Ngaage D.L., Cale A.R., Cowen M.E., Griffin S., and Guvendik L. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study. Ann Thorac Surg 86 (2008) 1195-1203
24. Ingels C., Debaveye Y., Milants I., et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J 27 (2006) 2716-2724
25. Ouattara A., Lecomte P., Le Manach Y., et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 103 (2005) 687-694
26. Goldman S., Copeland J., Moritz T., et al. Starting aspirin therapy after operation. Effects on early graft patency. Department of Veterans Affairs Cooperative Study Group. Circulation 84 (1991) 520-526
27. Cheng D.C., Karski J., Peniston C., et al. Morbidity outcome in early versus conventional tracheal extubation after coronary artery bypass grafting: a prospective randomized controlled trial. J Thorac Cardiovasc Surg 112 (1996) 755-764
28. Konstantakos A.K., and Lee J.H. Optimizing timing of early extubation in coronary artery bypass surgery patients. Ann Thorac Surg 69 (2000) 1842-1845